Apollo Endosurgery, Inc.
APEN · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 22% | 49.8% | -17.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 55.2% | 55.5% | 52.9% | 50.6% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -40.9% | -22.5% | -28.3% | -51.7% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -51.8% | -39.2% | -53.8% | -54.1% |
| EPS Diluted | -0.98 | -0.82 | -0.99 | -1.27 |
| % Growth | -19.5% | 17.2% | 22% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |